Equities
Teamshares secures $225M preferred equity investment from T. Rowe
Teamshares announced a $225 million preferred equity investment from T. Rowe.
Clarivate Announces Tender Offer Pricing for 2028 Notes
Clarivate has announced pricing for a tender offer related to its outstanding 2028 notes.
Alcoa Closes $2.6 Billion Senior Notes Offering
Alcoa has completed a senior notes offering of $2.6 billion, the company announced.
Wells Fargo chief risk officer to retire, COO to succeed him
Wells Fargo's chief risk officer will retire and be succeeded by the company's chief operating officer.
Oracle expands digital assets platform for banking operations
Oracle announced an expansion of its digital assets platform to support banking operations.
Mosaic Minerals Raises $592K for Golden Island Gold Drilling
Mosaic Minerals closed its first tranche of a $592,031 private placement and outlined plans for at least 2,500m of drill testing at its Quebec gold project.
OceanFirst Financial Corp Stock Drops to 52-Week Low of 17.04 USD
Shares of OceanFirst Financial Corp touched a new 52-week low of 17.04 USD, according to Investing.com company news.
Orchid Island stock hits 52-week low at 5.96 USD
The share price of Orchid Island fell to its lowest level in the past year.
HUHUTECH reports 8.6% revenue growth, expands global operations
HUHUTECH International Group Inc. reported a 8.6% increase in total revenue to $10.67 million for the six months ended June 30, 2026, driven by growth in China and new markets in the United States, Germany, and Singapore.
Viasat wins $307M Marine Corps satellite services contract
Viasat has been awarded a $307 million contract to provide satellite services to the U.S. Marine Corps.
Tortoise Energy Infrastructure stock hits 52‑week low at 40.3 USD
Tortoise Energy Infrastructure shares fell to a 52‑week low of 40.3 USD, per Investing.com.
Garanti BBVA Redeems EUR 30M MTN Issued in 2025
Turkish lender Garanti BBVA has completed redemption of a EUR 30 million medium-term note, originally issued abroad in September 2025.
Nvidia Trades at Decade-Low Valuation Despite Strong Growth Forecast
Nvidia shares trade at less than 17 times expected earnings, half the 2025 multiple, even as the company forecasts 90% revenue growth and 99% profit growth for fiscal 2027.
IonQ, Maplebear, Worthington Lead Premarket Moves
Shares of IonQ, Maplebear and Worthington Industries topped early movers ahead of the open on Wednesday, per CNBC's premarket watch.
Xenon Files Epilepsy Drug Bid, Pauses Psychiatry Programs on Safety Signals
Xenon Pharma submitted its first NDA for azetukalner in focal-onset seizures after strong Phase III data, while major depressive disorder and bipolar depression studies were halted following neuropsychiatric adverse events.
Target Declares $1.16 Quarterly Dividend, Marking 237th Consecutive Payout
Retailer raises payout to $1.16 per share with December 1 payment date; the quarterly distribution marks the company's 237th consecutive dividend since it went public in October 1967.
Surf Air Mobility signs second OperatorOS contract with SkyDance Air
Surf Air Mobility announced it has signed a second OperatorOS contract with SkyDance Air.
Judges Scientific H1 2026 profit drops 66% as revenue falls 21%
The UK‑based buy‑and‑build group reported adjusted operating profit of £4.8 million for the six months to 30 June, down 66% year‑on‑year, while revenue slipped 21% to £55.7 million.
Judges Scientific H1 2026 profit falls 72% as orders recover
Judges Scientific reported a 72% decline in profit for the first half of 2026 while noting a recovery in orders.
MHD stock hits 52-week low at 10.65 USD
Finance Review Daily is tracking this developing story; further verified details were not immediately available.
British Smaller Companies VCT launches up to £40m share offer
The VCT announced a new share issue targeting up to £40 million for the 2026/27 tax year, with an optional £20 million over‑allotment and fees of 3% or 3.5% depending on the sales channel.
Cardiol Expands MAVERIC Phase III Trial to 150 Patients
Cardiol Therapeutics Inc. increased its MAVERIC phase III trial enrollment to 150 patients after the Steering Committee recommended the expansion, aiming to assess CardiolRx’s efficacy in reducing recurrent pericarditis.
Stifel upgrades Microsoft to Buy, lifts price target to $575
Stifel raised Microsoft to a Buy rating, increasing its price target to $575 and citing mid‑to‑upper‑teens revenue growth, Azure upside and a slowdown in AI spending.
JD Sports H1 FY27 slides: sales hold up but margins compress
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.